Press Releases

MADISON, Wis., Nov. 19, 2019 /PRNewswire/ -- National E coli lawyer Jory Lange investigates an E coli outbreak in Wisconsin.  At leas

BALTIMORE, Nov. 19, 2019 /PRNewswire/ -- National E coli lawyer Jory Lange investigates an E coli outbreak linked to chicken Caesar s

DOYLESTOWN, Pa., Nov. 19, 2019 /PRNewswire/ -- Diverse Biotech, Inc. www.diversebiotech.com, has announced it has opened its Headquarters at the Pennsylvania Biotechnology Center

HOUSTON, Nov. 19, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, announced it now has preliminary data from its clinical trial of WP1220 for the treatment of cutaneous T-cell lymphoma ("CTCL"), which was p

SAN DIEGO, Nov. 19, 2019 /PRNewswire/ -- Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the initiation of a Phase 2b clinical trial of VK2809, its novel liver-selective thyroid hormone receptor b

DENVER, Nov. 19, 2019 /PRNewswire/ - HempFusion® ("the Company"), a leading Hemp/CBD company in the United States with distribution of its family of brands to over 3,900 retailers across 47 states, is pleased to announce the launch of the Company's North American, airport focused, CBD marketing campaign. The rollout includes advertisements

MONMOUTH JUNCTION, N.J., Nov. 19, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its

NEW YORK, Nov. 19, 2019 /PRNewswire/ -- 3DBio Therapeutics, an emerging leader in the field of 3D-bioprinting for human therapeutic use, today announced it has received Orphan Drug Designation for AuriNovo™, an investigational combination product for reconstruction of the outer ear in patients with microtia. Microtia is a rare congenital disorder causing the o

SOUTH SAN FRANCISCO, Calif., Nov. 19, 2019 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation oncology therapeutics, today announced that Bill Newell, CEO of S

NEW YORK and BASEL, Switzerland, Nov. 19, 2019 /PRNewswire/ -- Aruvant, a clinical stage biopharmaceutical company focused on developing and commercializing transformative therapies for the treatment of severe blood disorders, today announced the appointment of William Chou, M.D. as Chief Executive